Presentation is loading. Please wait.

Presentation is loading. Please wait.

Otitis Media and Eustachian Tube Dysfunction

Similar presentations


Presentation on theme: "Otitis Media and Eustachian Tube Dysfunction"— Presentation transcript:

1 Otitis Media and Eustachian Tube Dysfunction
R. Kent Dyer, Jr., M.D. Hough Ear Institute Oklahoma City, Oklahoma USA

2 Incidence of Otitis Media (OM)
Most common disease of childhood after viral URI 15 million cases of Acute OM/year in U.S. Cost of treatment: >$5 billion/year

3 Pathology of Acute Otitis Media
Viral or Bacterial Insult Edema Leukocyte Infiltration Purulent Exudate/Granulation Tissue ET Obstruction vs. Resolution Fibrosis

4 Pathogenesis of Otitis Media
Infection (viral vs. bacterial) Abnormal eustachian tube function Allergy (minor role) Neoplasm (nasopharyngeal carcinoma) Sinusitis

5 Eustachian Tube Function
Protection from nasopharyngeal secretions Ventilation Clearance of middle ear secretions

6 Otitis Media Classification
Classified according to: Duration of disease Acute, subacute, chronic Quality of effusion Serous, mucoid, purulent Tympanic membrane appearance

7 Acute Otitis Media Tympanic membrane: Opaque Bulging/injected
Reduced mobility Purulent effusion

8 Otitis Media with Effusion
Tympanic membrane: Translucent or opaque Gray/pink Reduced mobility Effusion present +/- air

9 Chronic Mucoid OM (Glue Ear)
Tympanic membrane: Opaque/gray Retracted, reduced mobility Thick effusion, no air Hearing loss (>20dB HL)

10 Tympanosclerosis White plaques in Lamina Propria Hyaline deposition
Significant conductive hearing loss possible

11 Obliterative Tympanosclerosis

12 Atelectasis Collapse or retraction of tympanic membrane
Often associated with ossicular pathology Long-standing eustachian tube dysfunction

13 Attic Retraction Isolated collapse of Pars Flaccida
May lead to cholesteatoma

14 Cholesteatoma Accumulation of squamous epithelium in middle ear & mastoid Osteolytic enzymes Often accompanied by chronic otorrhea

15 Slide No. 32 – Cholesteatoma – Schematic View
When a retraction pocket becomes large enough, the self-cleaning mechanism of the eardrum epithelium is altered. The usual process of epithelial migration and desquamation of death cells is interrupted, allowing large amounts of keratinous material to accumulate. The pressure induced by the expanding keratinous mass often associated with an infectious process accelerates the destructive expansion and lysis of the bony structures. This coronal schematic view of the ear canal and middle ear illustrates the pouching of the severe retractions, accumulation of debris and the destructive expansion involving the mastoid bone and middle ear ossicles. CHOLESTEATOMA A cholesteatoma is an epidermal inclusion cyst with expanding capabilities. It may not only involve the middle ear but through enlargement may involve and destroy adjacent structures. Several theories have been proposed about the pathogenesis of the cholesteatoma:  A) Retraction of the tympanic membrane with invagination, accumulation by trapping of keratinous material, expansion, and infection. B) Invasion by migration of the epithelium of the ear canal through a perforation and into the middle ear. C) Invasion and epithelial metaplasia of the basal cells of the external auditory meatus epithelium. D) Squamous transformation by metaplasia of the middle ear mucosa. E) Congenital. F) Iatrogenic (trapping of epithelium). There is enough evidence in the medical literature to support any of the theories. The most logical concept is to assume that the cholesteatomatous process may begin for any of those reasons. Still, clinically, by far the most observed process is the formation of cholesteatoma by the progressive retraction of the tympanic membrane. The progressive retraction forms a pocket where keratin accumulation begins inducing the formation of a cyst that expands prompting destruction of the osseous structures. Bony destruction may be due to osteoclastic action by the pressure of the cyst, or by a biochemical process induced by the epithelial walls of the cyst itself. The lytic bony process of the cholesteatoma is aggressive and may invade not only the ossicles but also the adjacent structures of the otic capsule. Extratemporal extension may invade intracranial or extracranial structures. The most common symptom of a cholesteatoma is loss of hearing. Cholesteatoma is not painful and otorrhea is infrequent. In children, the disease is diagnosed usually when the magnitude of the cyst is such that it becomes infected and produces a foul smelling otorrhea, resistant to medical treatment. At inspection, a retraction is recognized usually in the posterior superior aspect of the eardrum or the attic. There is accumulation of keratinous material and osseous defects, easy bleeding granulation tissue and polyps may be seen. Definitive treatment for cholesteatoma is surgical. Medical treatment with otic drops (antibiotics – anti-inflammatories) may be established to try to control the infectious process. Pseudomona aeruginosa, Bacteroides sp., and Peptostreptococcus are the most frequently isolated bacteria.

16 Chronic Suppurative Otitis Media
TM Perforation +/- cholesteatoma Otorrhea

17 Diagnosis of Otitis Media

18 Ear Examination Slide No. 6 – Ear Examination Normal Eardrum
This slide shows a normal eardrum. The pars tensa is of normal color and transparency. In the upper portion of the eardrum, the pars flaccida can be easily inspected. Other structures that can be seen include the umbo, the long and short process of the malleus, and the fibrous annulus. Through the transparency of the eardrum, the long process of the incus, the anterior crura of the stapes, and the stapes tendon can be seen. The corda tympani whitish shadow can be seen in the posterior superior aspect.

19 Pneumatic Otoscopy Essential for Diagnosis of OM
Keys: Air tight seal Adequate visualization of TM

20 Instrumentation

21 Tympanometry Useful for confirming diagnosis (if pneumatic exam inadequate) Type C (negative peak) Suggests ET dysfunction Type B (flat) + effusion

22 Acute Otitis Media Microbiology: S. pneumoniae H. influenza
20-30% PCN resistant H. influenza 30-60% B-Lactamase + M. catarrhalis 90-95% B-Lactamase +

23 Acute Otitis Media (Day 2)

24 Acute Otitis Media (1 Week)

25 Chronic Serous Otitis Media
Microbiology: 50% of effusions culture + for bacteria S. pneumoniae, H. influenza, M. catarrhalis

26 Serous Otitis Media

27 Chronic Suppurative Otitis Media
Microbiology: P. aeruginosa S. aureus Diphtheroids Klebsiella

28 Management of Acute Otitis Media
Amoxicillin 90mg/kg/day Mild PCN allergy (rash) Cephalosporin Severe PCN allergy (anaphylaxis) Azithromycin Clarithromycin

29 2nd Line Therapy for Otitis Media
Amoxicillin/Clavulanate Oral Cephalosporin (2nd or 3rd generation) Macrolide Ceftriaxone (IM)

30 When to Consider 2nd Line Rx
Group day care Antibiotic Rx within last 30 days Failure of antibiotic prophylaxis Refractory AOM Failure to improve with 72 hours

31 Management of Persistent OM
                                       Management of Persistent OM Watchful waiting 90% of effusions will resolve within 3 months Additional 2nd line antibiotics Intranasal steroids Eustachian tube inflation Valsalva vs. Otovent Nasal endoscopy

32 Factors to Consider with Long-standing Effusions
Degree of hearing loss (>20dB HL) Vertigo/imbalance Tympanic membrane changes (retraction) Speech & language delay Behavioral changes Frequency & severity of AOM

33 Plan of Therapy Amoxil

34 Plan of Therapy Amoxil If No Improvement in 72 hrs.

35 Plan of Therapy Amoxil 2nd Line Antibiotic
If No Improvement in 72 hrs.

36 Plan of Therapy Amoxil 2nd Line Antibiotic
If No Improvement in 72 hrs. If Persistent Effusion

37 2nd Line Antibiotic/Monitor (up to 3 months)
Plan of Therapy Amoxil 2nd Line Antibiotic 2nd Line Antibiotic/Monitor (up to 3 months) If No Improvement in 72 hrs. If Persistent Effusion

38 Plan of Therapy Amoxil 2nd Line Antibiotic
2nd Line Antibiotic/Monitor (up to 3 months) Modify Risk Factors (when possible) & Check Hearing Status If No Improvement in 72 hrs. If Persistent Effusion

39 Plan of Therapy Amoxil 2nd Line Antibiotic
2nd Line Antibiotic/Monitor (up to 3 months) Modify Risk Factors (when possible) & Check Hearing Status Tympanocentesis usually not indicated If No Improvement in 72 hrs. If Persistent Effusion

40 Indications for Tympanostomy Tubes
>5 episodes of AOM in 6-9 months Persistent ME effusion x 3 months Complication of OM Failure of antibiotic prophylaxis Acute Mastoiditis

41 Indications for Tympanostomy Tubes
Craniofacial anomaly Structural changes to TM Speech & language delay

42 Serous Otitis Media w/Retraction

43 Choice of Tubes Short-lasting (6-12 mo.) Intermediate (12-18 mo.)
Long-lasting (>18 mo.)

44 Straight Vent Tube Shaft Lumen Medial flange

45 Grommet/Bobbin Style Lumen Flanges

46 TUBE INDUCED PERFORATION
T TYPE Vent tube Medial Flange Shaft TUBE INDUCED PERFORATION “GOODE T - TUBE” - Xomed

47 Post-tube Otorrhea Usually secondary to URI or water exposure
Topical antibiotic usually adequate 5-7 days (Floxin, Ciloxin, Ciprodex)

48 Water Precautions Cotton + Vaseline when bathing Plug
Ear Band-It when swimming

49 Refractory Otorrhea Consider fungal etiology Clotrimazole gtts
Amphotericin B powder Cresylate Debridement of ear canal Water Precautions No H2O2!!!

50 Tube Removal Removal recommended if tube persists >24 months
Risk of TM perforation 12-25% if tube retained >2 years

51


Download ppt "Otitis Media and Eustachian Tube Dysfunction"

Similar presentations


Ads by Google